-transparent.png){kind=logo}
Blood platelets have been shown to play an important role not only in thrombosis, but also in the pathogenesis of coronary artery disease and its complications. Drugs that affect platelets have been shown to reduce mortality in survivors of acute myocardial infarction, to reduce the risk of myocardial infarction in patients with unstable angina, and to preserve the potency of saphenous venous grafts used to bypass obstructed coronary arteries. The drugs may also play a role in the primary prevention of arteriosclerosis and in preventing thrombotic complications following coronary angioplasty.
Related Publications
K P Miller, and
W H Frishman
January 2004,
The New England journal of medicine,
K P Miller, and
W H Frishman
May 2004,
The New England journal of medicine,
K P Miller, and
W H Frishman
February 1981,
Journal of the South Carolina Medical Association (1975),
K P Miller, and
W H Frishman
January 1980,
The New England journal of medicine,
K P Miller, and
W H Frishman
January 2016,
Current atherosclerosis reports,
K P Miller, and
W H Frishman
January 2012,
Handbook of experimental pharmacology,
K P Miller, and
W H Frishman
October 1998,
American heart journal,
K P Miller, and
W H Frishman
January 2000,
The Medical clinics of North America,
K P Miller, and
W H Frishman
January 2011,
Journal of atherosclerosis and thrombosis,
K P Miller, and
W H Frishman
August 1996,
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego,
